<- Go Home

ChemoMetec A/S

ChemoMetec A/S engages in the development, production, and sale of analytical equipment for cell counting and analysis the United States, Canada, Europe, and internationally. The company offers its solutions in the areas of cell and gene therapy, cancer and stem cell research, and development and manufacturing of pharmaceuticals, as well as production and quality control of animal semen, milk, and beer. Its products include NucleoCounter NC-3000, an advanced image cytometer; NucleoCounter NC-250, an automated cell analyzer; NucleoCounter NC-202, a consistent cell counter; NucleoCounter NC-200, an automated cell counter that provides solution for cell counting and cell viability determination; NucleoCounter SP-100, an automated sperm cell counter for use in animal reproduction; and XcytoMatic 40, a cell density and viability analyzer. In addition, the company provides consumables comprising cassettes, reagents, lysis, and slides; accessories, which include cables, power supplies, software, and labware products, as well as service and validation plans and training. Further, it develops as well as develops XcytoMatic 30 cell counter. ChemoMetec A/S was incorporated in 1997 and is headquartered in Allerød, Denmark.

Market Cap

DKK 9.4B

Volume

72.0K

Cash and Equivalents

DKK 264.7M

EBITDA

DKK 220.0M

Tax Rate Collected

N/A

Tax Rate Ratio

N/A

Gross Profit

DKK 418.5M

Profit Margin

91.07%

52 Week High

DKK 616.00

52 Week Low

DKK 332.40

Dividend

0.74%

Price / Book Value

15.66

Price / Earnings

55.35

Price / Tangible Book Value

20.14

Enterprise Value

DKK 9.1B

Enterprise Value / EBITDA

41.39

Operating Income

DKK 210.3M

Return on Equity

30.83%

Return on Assets

19.86

Cash and Short Term Investments

DKK 264.7M

Debt

DKK 7.8M

Equity

DKK 598.0M

Revenue

DKK 459.5M

Unlevered FCF

DKK 98.1M

Sector

Life Sciences Tools and Services

Category

N/A

Hedge Funds that own this stock

PREMIUM

Upgrade to Yellowbrick Premium to unlock the Professional Funds that own this company (and many other perks).

Upgrade to Yellowbrick Premium

Yellowbrick Portfolios that own this stock

PREMIUM

Upgrade to Yellowbrick Premium to unlock the Yellowbrick portfolios that own this company (and many other perks).

Upgrade to Yellowbrick Premium

Company Stock Pitches